About Michael A. S. Guth, Ph.D., J.D.
Prior to entering law school, Dr. Michael Guth worked as an investment banker in Europe for Deutsche Bank and Credit Suisse First Boston from late 1989 – 1992. When he returned to the United States in 1992, he broadened his risk management skills to include human health and environmental risks from contamination at the Oak Ridge, TN, Department of Energy facilities.
In the fall of 1994, Michael Guth decided to combine his background in financial economics with a law degree, and pursue a possible career in corporate mergers and restructurings. Large corporate law firms might perceive an advantage in hiring a corporate associate who knew something about capital markets, asset valuation, and related corporate finance concepts. Here are the results of his law school studies as well as his educational background:
J.D., Summa Cum Laude, College of Law, Dec. 1997, University of Tennessee, Knoxville.
Ph.D., (Financial) Economics, March 1988, University of Tennessee, Knoxville.
During his second year in law school, Michael Guth noticed an unusually high number of convergence mergers between electric utilities and gas companies, as well as mergers among electric utilities. This merger activity led him to pursue work directly in the power industry, where he might have the opportunity to see the planning for a merger first-hand. During his second year of law school, he began working for the Tennessee Valley Authority (TVA) to work on their power business trading floor as a quantitative finance consultant. He worked for TVA part-time during his second year in law school, and then he was fortunate to receive an offer to join the agency full-time as a consultant upon completion of his law school studies. Thus began his career in the power and gas industry over the period 1997 – 2002, which would culminate in his consulting or working for Pacific Gas & Electric’s unregulated National Energy Group, Oklahoma Gas and Electric’s unregulated power trading group, General Electric Power Systems, and Progress Energy.
From 2002 to the present, he has worked on Health Economics and Outcomes Research (HE&OR). Michael Guth is realtively unique among Pharmacoeconomics and Outcomes Researchers in that his professional career has focused on driving down the costs of health care for all consumers. Most health economists work for pharmaceutical firms and study their brand drugs. In contrast, Michael has conducted clinical research on new indications for generic drugs as well as studies on the efficacy of generic hormone drugs in decelerating the process of aging. He has also researched and published on the use of generic compounded solutions for flushing and store of grafts used in coronary artery bypass graft (CABG) surgery.
As an invited speaker for an executive forum on diabetes practice management, Dr. Guth mentioned food is more than something to eat for pleasure or to appease hunger. Food is the most important drug we will consume, at least three times per day, for the rest of our lives. Every morsel of food should be consumed with with a view to how it will affect the insulin-glucagon balance.
For more than fifteen years, he been interested in health and nutrition, but beginning in 1997, he began to read the medical literature on clinical trials and research related to Alzheimer’s disease and developed some expertise on the treatments available for this disease. That research in turn led him to investigate treatments, both prescription drug and nonprescription compounds, for hyperlipidemia and osteoporosis. Dr. Guth is a strong proponent of individual patient self-education on health issues and managing one’s own health. He now consults in the area of employee health and wellness, health outcomes research, market access, medical ethics, and age-related disease prevention, in addition to practicing law and teaching Health Economics.